Jump to content
Knowledge Hub

News Archive

EMA - Human Medicines Newsletter 178

13th March 2024

Edition 178, March 2024

Read More+

EMA - Meeting highlights from the PRAC 4-7 March 2024

13th March 2024

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC)

Read More+

FDA - Final Guideline: Q14 Analytical Procedure Development AND Q2(R2) Validation of Analytical Procedures

13th March 2024

Released March 2024

Read More+

FDA - Roundup 12th March 2024

13th March 2024

An at-a-glance summary of news from around the agency.

Read More+

MHRA - Equity in Medical Devices

13th March 2024

The MHRA welcomes the publication of Dame Margaret Whitehead’s Equity in Medical Devices: Independent Review

Read More+

MHRA - Med Tech Regulatory Reform blog

13th March 2024

March Edition

Read More+

EMA - Launch of new HMA-EMA catalogues of real-world data sources and studies

29th February 2024

EMA and the Heads of Medicines Agencies (HMA) have launched two public electronic catalogues: one for real-world data (RWD) sources and one for RWD studies.

Read More+

EMA - Meeting highlights from the CHMP 19-22 February 2024

29th February 2024

Committee for Medicinal Products for Human Use (CHMP) 19-22 February 2024

Read More+

EMA - Meeting highlights from the CVMP 13-14 February 2024

29th February 2024

Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 13-14 February 2024

Read More+

EMA - Multi-agency report highlights importance of reducing antibiotic use

29th February 2024

Countries that have decreased their consumption of antibiotics in both animals and humans have seen a reduction in antibiotic-resistant bacteria.

Read More+
« Previous | Page 42 of 128 | Next »

Share